Evidence map›Paper›PMID 28078184›Full record

ArticleAmerican journal of nuclear medicine and molecular imaging2016

Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis.

Mojtaba Ghasemi, Iraj Nabipour, Abdolmajid Omrani, Zeinab Alipour, Majid Assadi

Open access · greenAbstract read
In one paragraph

Article in American journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. The Role of Molecular Imaging in Personalized Medicine.Journal of personalized medicine · 2023
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. SUVAmerican journal of nuclear medicine and molecular imaging · 2021
    Article
  16. Review
  17. Standardized uptake value (SUVCancer biology & therapy · 2020
    Article
  18. An aggressive functioning pituitary adenoma treated with peptide receptor radionuclide therapy.European journal of nuclear medicine and molecular imaging · 2020
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mojtaba GhasemiThe Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; Young Researchers and Elite Club, Bushehr Branch, Islamic Azad UniversityBushehr, Iran.
Iraj NabipourThe Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; The Future Studies Group, Iranian Academy of Medical SciencesTehran, Iran.
Abdolmajid OmraniDivision of clinical studies, The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences Bushehr, Iran.
Zeinab AlipourDivision of clinical studies, The Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical Sciences Bushehr, Iran.
Majid AssadiThe Persian Gulf Nuclear Medicine Research Center, Bushehr University of Medical SciencesBushehr, Iran; Department of Molecular Imaging and Radionuclide Therapy (MIRT), Bushehr Medical University Hospital, Bushehr University of Medical SciencesBushehr, Iran.
Bushehr University of Medical Sciences · IRIslamic Azad University, Bushehr Branch · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a review of the importance and role of precision medicine and molecular imaging technologies in cancer diagnosis with therapeutics and diagnostics purposes. Precision medicine is progressively becoming a hot topic in all disciplines related to biomedical investigation and has the capacity to become the paradigm for clinical practice. The future of medicine lies in early diagnosis and individually appropriate treatments, a concept that has been named precision medicine, i.e. delivering the right treatment to the right patient at the right time. Molecular imaging is quickly being recognized as a tool with the potential to ameliorate every aspect of cancer treatment. On the other hand, emerging high-throughput technologies such as omics techniques and systems approaches have generated a paradigm shift for biological systems in advanced life science research. In this review, we describe the precision medicine, difference between precision medicine and personalized medicine, precision medicine initiative, systems biology/medicine approaches (such as genomics, radiogenomics, transcriptomics, proteomics, and metabolomics), P4 medicine, relationship between systems biology/medicine approaches and precision medicine, and molecular imaging modalities and their utility in cancer treatment and diagnosis. Accordingly, the precision medicine and molecular imaging will enable us to accelerate and improve cancer management in future medicine.

Indexed as

cancer theranosticsmetabolomics-based systems medicinemolecular imagingP4 medicinePrecision medicineprecision medicine initiativeradio-omicssystems biology

Identifiers

PMID28078184
PMCPMC5218860
OpenAlexW2883847415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.